Myriad Genetics (MYGN)
(Delayed Data from NSDQ)
$27.64 USD
-0.65 (-2.30%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $27.56 -0.08 (-0.29%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Myriad Genetics (MYGN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$29.85 | $40.00 | $18.00 | 5.51% |
Price Target
Based on short-term price targets offered by 13 analysts, the average price target for Myriad Genetics comes to $29.85. The forecasts range from a low of $18.00 to a high of $40.00. The average price target represents an increase of 5.51% from the last closing price of $28.29.
Analyst Price Targets (13)
Broker Rating
Myriad Genetics currently has an average brokerage recommendation (ABR) of 2.36 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 2.42 a month ago based on 12 recommendations.
Of the 14 recommendations deriving the current ABR, six are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 42.86% and 7.14% of all recommendations. A month ago, Strong Buy made up 41.67%, while Buy represented 8.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 5 | 5 | 5 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 3 | 3 | 3 | 3 |
Sell | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.36 | 2.31 | 2.42 | 2.42 | 2.42 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/9/2024 | Guggenheim Securities | Subbu Nambi | Strong Buy | Strong Buy |
8/27/2024 | Wells Fargo Securities | Brandon Couillard | Not Available | Strong Buy |
8/21/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/13/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/12/2024 | Piper Sandler | David M Westenberg | Hold | Hold |
8/7/2024 | Cowen & Co. | Daniel Brennan | Hold | Hold |
6/27/2024 | Scotiabank | Sung-Ji Nam | Not Available | Strong Buy |
6/3/2024 | Not Identified | Not Identified | Not Available | Moderate Sell |
5/8/2024 | SVB Securities | Puneet Souda | Hold | Strong Buy |
5/1/2024 | Stephens | Mason Carrico | Hold | Hold |
1/30/2024 | Goldman Sachs | Matthew Sykes | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.36 |
ABR (Last week) | 2.31 |
# of Recs in ABR | 14 |
Average Target Price | $30.00 |
LT Growth Rate | 51.30% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | 0.02 |
MYGN FAQs
Myriad Genetics, Inc. (MYGN) currently has an average brokerage recommendation (ABR) of 2.36 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms.
The average price target for Myriad Genetics, Inc. (MYGN) is $30.00. The current on short-term price targets is based on 9 reports.
The forecasts for Myriad Genetics, Inc. (MYGN) range from a low of $18 to a high of $40. The average price target represents a increase of $8.54 from the last closing price of $27.64.
The current UPSIDE for Myriad Genetics, Inc. (MYGN) is 8.54%
Based on short-term price targets offered by 13 analysts, the average price target for Myriad Genetics comes to $29.85. The forecasts range from a low of $18.00 to a high of $40.00. The average price target represents an increase of 5.51% from the last closing price of $28.29.